Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2026 08:40 ET | Source: Fortis Life Sciences

Fortis Life Sciences Awards 2026 AbNano® VHH Discovery Grant to Deliver Biosciences for Targeted Drug Delivery Research

Fortis Life Sciences awards Deliver Biosciences the 2026 AbNano® VHH Discovery Grant for in vivo CAR-T, gene therapy & nanoparticle drug delivery research
May 08, 2026 09:39 ET | Source: Research and Markets

Europe's $154+ Million AI in Antibody Discovery Market, 2025-2035: Precision Therapies and AI Integration Spur Market Transformation

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Europe AI in Antibody Discovery Market: Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The Europe AI in...
May 07, 2026 08:56 ET | Source: Research and Markets

Asia-Pacific AI in Antibody Discovery Research Report 2026: $1.24 Bn Market Analysis and Forecast 2025-2035 - Rapid Adoption of AI Across Emerging Biopharma Hubs

Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Asia-Pacific AI in Antibody Discovery Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...
April 28, 2026 04:01 ET | Source: Research and Markets

AI in Antibody Discovery Market Research Report 2025-2035: Surging Demand for Next-Generation Biologics and Leveraging AI for Personalized Precision Medicine in Antibody Discovery Gaining Traction

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "AI in Antibody Discovery Market - A Global and Regional Analysis: Focus on Technology, Solution, Application, End User, and Country, 2025-2035" report...
April 21, 2026 06:10 ET | Source: Research and Markets

Chronic Granulomatous Disease (CGD) Market Analysis and Outlook Report 2026-2036 - Emerging Gene Therapies, Lentiviral Vector-based Therapies and CRISPR-Cas9 Gene Editing, Ignite Hope

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Chronic Granulomatous Disease Market: Focus on Treatment Type, Route of Administration, Distribution Channel, Country and Regional Analysis,...
April 21, 2026 04:13 ET | Source: Research and Markets

Trispecific Antibodies Market Landscape Report 2026: Opportunity and Proprietary Insights - 90 Trispecific Antibodies by Company, Country, Indication & Phase

Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Trispecific Antibodies Market Opportunity, Proprietary Technologies & Clinical Trials Insight 2026" report has been added to ...
April 13, 2026 05:47 ET | Source: Research and Markets

Bispecific Antibodies Market Research and Competitive Landscape Report 2026: Comprehensive Insights Into Over 180 Companies and 250 Drugs

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Bispecific Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive...
April 01, 2026 07:15 ET | Source: Research and Markets

Next Generation Antibody Therapeutics Market Report 2026 (2nd Edition): Key Geographical Regions, Business Opportunities and Leading Players

Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Antibody Therapeutics Market (2nd Edition): Industry Trends and Global Forecasts, Till 2035 - Distribution by Drug, Type of Novel...
March 02, 2026 04:04 ET | Source: Research and Markets

Monoclonal Antibodies (mAbs) for Oncology Global Report 2026: A $228 Billion Market by 2030, Driven by Technological Advances, New Product Launches, Label Expansions, Increasing Prevalence

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies for Oncology: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for monoclonal...
February 18, 2026 10:32 ET | Source: Research and Markets

Monoclonal Antibodies Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 230+ Drugs by Company, Product, Stage of Development, Route of Administration, Molecule Type

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers a detailed analysis...